Keeping You on the Cutting Edge
This series will describe periprocedural interruption of anticoagulation in patients with nonvalvular atrial fibrillation, including the role of bridging, and differences in management of warfarin and direct oral anticoagulants.
This series of activities will describe the efficacy and safety of DOACs in atrial fibrillation, including standard practices for managing DOACs, strategies for avoiding drug-drug interactions and dosing errors with DOACs, and best practices of DOAC use in specific clinical scenarios.
This series of activities explores recent data on the potential effect of weight loss and other factors such as exercise on reducing the incidence of atrial fibrillation.
This series will discuss studies leading to ACC/AHA guideline recommendations on prophylactic implantable cardioverter defibrillators (ICDs).
This series will discuss the emergence of left atrial occlusion devices as alternatives for stroke prevention in patients with atrial fibrillation who are not ideal candidates for long-term warfarin therapy.
This series of activities will address the guidelines and use of wearable cardioverter-defibrillators (WCDs).
This series of activities will review the current treatment options for atrial fibrillation, specifically antiarrhythmic drugs and catheter ablation, as well as the results of the CABANA trial and how the results impact the treatment of patients with atrial fibrillation.
This series of activities will review contemporary pacing techniques,
This series will describe cardiac surgery infections caused by
Diagnose and manage a man who presents with fatigue, loss of appetite, abdominal pain, and peripheral edema.
Diagnose and manage a man with abdominal pain who has experienced significant weight loss over a period of one year.
Clinical Support Content
Medical errors continue to be a leading cause of death in the United States. However, there are steps that can be taken to reduce patient harm and promote a safer environment for patients. Explore these lesson to find out how.
Examine the key fundamentals of documentation that are important for communication of care, quality reporting, and billing.
This series of activities will discuss palliative care practices and summarize recent guidelines for the role of palliative care in heart failure.
Congenital Heart Disease
Diagnose and manage a man who has experienced progressive fatigue and chest pain over the past year.
This series will describe the pros and cons of PFO closure and key issues surrounding the management of patients with PFO.
Coronary Artery Disease
This series of activities explore the recent changes to the ACC/AHA guideline recommendations regarding the duration of dual antiplatelet therapy (DAPT) in patients with coronary artery disease.
Determine the best approach to manage a patient who has experienced cardiac arrest while on his way to a doctor’s appointment.
Diagnose and manage a man with rheumatoid arthritis who is experiencing fatigue and chest pain upon exertion.
Based on the 2016 ACC/AHA guideline recommendations, this series of activities examines how to best manage dual antiplatelet therapy for patients who require noncardiac surgery.
Interpreting and using information from the ORBITA trial in the management of patients with stable angina and coronary artery disease.
This series will explore antiplatelet therapy decision-making for patients with atrial fibrillation who have undergone PCI.
This series of activities evaluates the guideline recommendations and new clinical trials for interventionalists in the management of left main CAD with experts weighing in on the pros and cons of PCI and CABG in different patient populations.
Coronary artery calcium (CAC) scoring can help better inform patient risk for coronary heart disease (CHD). This set of activities examine which patients may benefit most from CAC scoring and interpretation of CAC scores to assess 10-year CHD risk.
Explore recent data for new and emerging antidiabetic agents shown to reduce CV events in patients with type 2 diabetes mellitus and cardiovascular disease (CVD), and discuss the pivotal role of cardiologists in reducing negative CVD outcomes.
This series of activities examines guideline recommendations for the use of non-statin therapy in individuals with dyslipidemia.
This series of activities clarifies current guidelines for ASCVD risk assessment and lipid management, with a focus on practical statin decision-making for intermediate risk patients.
This series of activities examines the recent findings on the cardiovascular safety of NSAIDs and selective COX-2 inhibition in patients with osteoarthritis or rheumatoid arthritis.
This series of activities will discuss the relationship between type 2 diabetes mellitus (T2DM) and heart failure (HF), including the efficacy and safety of treatment strategies.
This series of activities will address the current guideline recommendations and features of troponin assays in clinical care.
This series of activities will provide basic foundational content on the relationship between nutritional supplements and the heart; and discuss the evidence (and lack thereof) for dietary supplements in the management of cardiovascular disease (CVD).
This series of activities will review screening and risk assessment tools used to guide decision making for the treatment of clinical atherosclerotic cardiovascular disease (ASCVD); as well as the guideline-based strategies for a) lipid management to reduce ASCVD risk, b) cholesterol management in non-diabetic individuals without clinical ASCVD, and c) individuals with clinical ASCVD or Diabetes Mellitus (DM).
Heart Failure and Cardiomyopathy
Determine whether a patient with chest pain is a candidate for revascularization.
This series of activities explores recent data surrounding the use of revascularization as a management strategy for patients with ischemic cardiomyopathy and coronary artery disease.
Diagnose and manage a woman who presents with sudden onset dizziness, nausea, and imbalance.
This series discusses the rationale for the updated 2017 heart failure guideline management recommendations and their implementation.
This series of activities discusses how to prescribe appropriate drug treatment regimens based on patients’ individual risk and the need the need to optimize guideline-directed medical therapy (GDMT).
This series of activities will discuss diagnosis and treatment of iron deficiency in patients with heart failure.
This series will explore the importance of imaging in the diagnosis of hypertrophic cardiomyopathy (HCM) and the appropriate management strategies for various clinical scenarios.
This module will address the necessity of assessing for sleep apnea (SA) in heart failure (HF) as a common comorbidity that affects prognosis, clinical outcomes associated with treatment of SA in HF patients, differences in treatment strategies in central sleep apnea (CSA) versus obstructive sleep apnea (OSA) in patients with HF, potential harm with use of adaptive servo-ventilation in patients with CSA and heart failure with reduced ejection fraction (HFrEF).
This series of activities will address cardiovascular (CV) risk and cardiovascular disease (CVD) in patients with diabetes mellitus (DM), as well as risk management strategies for supporting patients with known CVD and DM.
The purpose of this activity is to distinguish between the main subtypes of cardiac amyloidosis (CA), recognize the features and clinical presentation of cardiac amyloidosis, and to summarize methods available to diagnose, treat and manage CA.
Systemic Disorders Affecting the Circulatory System
This series of activities explores the presentation, diagnosis, treatment, and management of infective endocarditis.
This series of activities will review the risk factors, treatment, and prevention strategies for pulmonary embolism (PE), as well as the structure and benefit of the Pulmonary Embolism Response Team (PERT).
Systemic Hypertension and Hypotension
This module examines the updated 2017 ACC/AHA guidelines for blood pressure management that focus on the preventive benefits of lower pressure targets.
This series of activities explores treatment modalities for aortic stenosis, including TAVR and SAVR, based on patients’ individual risk.
Bioprosthetic aortic valve leaflet thrombosis is more common than previously recognized. This series of activities will examine best practices for diagnosing and managing subclinical aortic valve leaflet thrombosis.
This series will discuss the evaluation, diagnosis, and management of functional mitral regurgitation.
This series of activities discuss current guideline recommendations and clinical challenges associated with anticoagulation therapy in pregnant women with mechanical heart valves.
This series of activities will discuss the etiology and mortality of paravalvular leak (PVL) as a complication of prosthetic valve implantation, as well as describe how to best diagnose, assess, and manage PVL in clinical practice.
Diagnose a woman who suddenly loses consciousness while standing in line at the cafeteria.
Diagnose and manage a woman who presents with a murmur after a recent car accident.
Manage a patient with a history of aortic valve replacement presenting with chest pain.
This series of activities reviews the basic principles and symptom profile of the COVID-19 infected patient with progressive respiratory failure; the pathophysiology that contributes to the deteriorating respiratory status and progression of other organ failure; and strategies for the diagnosis, treatment, and management of the COVID-19 infected patient.
This series of activities will review acute cardiac injury as it relates to the COVID-19 infected patient; assessment and diagnostic techniques for identifying progressive cardiovascular disease in the COVID-19 infected patient; and various treatment options for the management of the COVID-19.